Development & Policy | June 2026 | 5 min read
⚡ Quick Takeaways
- The National Agricultural Biotechnology Policy 2025 has been approved to guide modern crop technology in Pakistan.
- The policy focuses on food security, better yields, responsible regulation and private-sector investment.
- GM maize remains a key test case because its approvals and trials are central to the current debate.
- Supporters say higher productivity can strengthen poultry feed supply, maize exports and farmer income.
- Implementation will decide whether the policy becomes a practical reform or stays only on paper.
Pakistan’s approval of the National Agricultural Biotechnology Policy 2025 marks an important moment for the country’s agriculture sector, which is under pressure from rising input costs, climate stress, pest attacks and growing demand for food and feed. The policy is being presented as a way to bring science, regulation and investment together so farmers can access improved technologies under a predictable framework.
| 2.5 Years Consultative policy process |
10% to 46% Reported GM maize yield advantage |
Up to $1bn Possible maize export potential over time |
Policy Approval Gives Agriculture a Clearer Direction
The policy gives Pakistan a formal national direction for agricultural biotechnology at a time when productivity gaps are becoming harder to ignore. Farmers are facing higher seed, fertiliser, fuel and pesticide costs, while crop losses from pests and changing weather patterns continue to affect farm income. In this environment, biotechnology is not a replacement for good farming practices or conventional breeding. It is an additional tool that can support stronger crop performance when used with proper agronomy, local research and safety checks.
The policy was prepared after a long consultation process involving scientific, regulatory, farming, industry and policy stakeholders. That matters because biotechnology decisions need public confidence, legal clarity and technical review. A predictable system can also encourage responsible investment while giving farmers clearer access to approved products.
| Policy Focus: The main test is not only approval on paper, but timely implementation through transparent, science-based rules. |
GM Maize Becomes the First Major Test Case
GM maize is at the centre of the discussion because it has already moved through Pakistan’s statutory biosafety and regulatory process, according to the information shared in the article. The process started with biosafety trials in 2009, followed by completion of required studies and data generation in 2013. Later commercialization approvals were granted after regulatory review. The trials were also conducted under the supervision of the Field Monitoring Committee, which was constituted by the Technical Advisory Committee and the National Biosafety Committee.
Supporters of the technology argue that this history shows the crop did not appear suddenly in the policy debate. It has been tested, reviewed and discussed for years. GM maize hybrids also completed National Uniformity Yield Trials in 2017 and 2018 across multiple locations under regulatory supervision. Published trial data cited in the source article showed yield advantages ranging from 10 percent to 46 percent across hybrids from different companies. These numbers are important because maize is closely linked with the poultry and animal feed sectors, where stable supply and price management matter for consumers as well as farmers.
Key Maize and Biotechnology Indicators
| Indicator | Reported Detail | Why It Matters |
| Policy status | National Agricultural Biotechnology Policy 2025 approved | Creates national direction for biotech regulation and commercialization |
| GM maize trials | Biosafety trials began in 2009; studies completed in 2013 | Shows the crop has passed through a long review cycle |
| Yield advantage | 10% to 46% reported across hybrids | Could help improve productivity and farmer returns |
| Poultry feed use | Around 70% of maize grain consumed by poultry | Links maize productivity with feed costs and food prices |
| Export potential | Maize exports could move toward $1 billion over time | Depends on productivity, quality, market access and implementation |
Feed Demand and Exports Raise the Economic Stakes
Pakistan’s maize grain market is already strongly connected with the feed industry. Poultry is described as the largest consumer, using around 70 percent of maize grain, followed by animal feed at about 15 percent and wet milling at around 10 to 12 percent. A stronger maize crop may support feed mills, poultry producers, meat and egg prices, and rural income chains.
Pakistan’s maize grain exports have recently been cited around $288 million to $345 million annually, while fodder and forage exports add more feed-related value under broader categories. If approved technologies improve productivity and quality, supporters believe Pakistan could gradually expand its grain and feed export base, potentially reaching up to $1 billion over time. However, this outcome would depend on consistent regulation, market access, quality standards, logistics and buyer confidence.
| Farmer Impact: Better seed technology can help only when farmers also receive quality seed, extension support, market access and clear guidance. |
Implementation Will Decide the Policy’s Real Value
The approval of the policy is only the first step. The real challenge is implementation in true letter and spirit. Pakistan needs a system that protects biosafety, supports farmer choice, encourages lawful commercialization and avoids unnecessary delays after statutory requirements have been completed. Without this, the policy may fail to deliver practical benefits for growers, investors and consumers.
The coming months will show whether the country can move from policy approval to meaningful action. Further delays could limit farmer access to approved technologies, weaken investor confidence and slow public-private collaboration. A transparent, science-based and well-regulated framework can help Pakistan strengthen food security, reduce avoidable losses, improve export competitiveness and build a more resilient agricultural future.
| Caution: Biotechnology should move forward through verified approvals, clear labelling where required, farmer education and strong regulatory oversight. |
Disclaimer: This article is based on the provided source text and available public reporting. Policy implementation, approvals and market outcomes may change over time.
